Helio Genomics and LiverRight have entered into a partnership designed to improve access to early liver cancer detection in the US.

New research highlights the promise of artificial intelligence (AI) for opportunistic screening of chronic liver disease (CLD) through routine echocardiography. “We hope that this algorithm enables ...